Pages that link to "Q39730471"

The following pages link to A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. (Q39730471):

Displaying 26 items.

• Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? (Q26766574) (← links)
• Management of endocrine disease: Diabetes and osteoporosis: cause for concern? (Q26798968) (← links)
• Involvement of Prolyl Hydroxylase Domain Protein in the Rosiglitazone-Induced Suppression of Osteoblast Differentiation (Q28548626) (← links)
• c-Maf and you won’t see fat (Q34162249) (← links)
• Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity (Q34402668) (← links)
• β-catenin directly sequesters adipocytic and insulin sensitizing activities but not osteoblastic activity of PPARγ2 in marrow mesenchymal stem cells (Q34525599) (← links)
• Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells (Q34983695) (← links)
• An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss (Q35755747) (← links)
• The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation Process (Q35889780) (← links)
• Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications. (Q35998796) (← links)
• Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues (Q37071194) (← links)
• Vitamin D endocrine system and osteoblasts. (Q37620405) (← links)
• Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. (Q38157926) (← links)
• Vitamin D and gene networks in human osteoblasts. (Q38208297) (← links)
• The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis (Q38537377) (← links)
• Modified protocol for improvement of differentiation potential of menstrual blood-derived stem cells into adipogenic lineage. (Q39123899) (← links)
• PPARγ suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells (Q39436656) (← links)
• Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction. (Q53379079) (← links)
• Activation of PPAR-γ inhibits differentiation of rat osteoblasts by reducing expression of connective tissue growth factor. (Q54188393) (← links)
• VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity (Q58091922) (← links)
• Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats (Q58744410) (← links)
• Correlation of spontaneous adipocyte generation with osteogenic differentiation of porcine skin-derived stem cells (Q61810531) (← links)
• High Glucose Level Impairs Human Mature Bone Marrow Adipocyte Function Through Increased ROS Production (Q90265184) (← links)
• Progress and Applications of Polyphosphate in Bone and Cartilage Regeneration (Q92188664) (← links)
• Peroxiredoxin II negatively regulates BMP2-induced osteoblast differentiation and bone formation via PP2A Cα-mediated Smad1/5/9 dephosphorylation (Q92501704) (← links)
• Cinacalcet attenuated bone loss via inhibiting parathyroid hormone-induced endothelial-to-adipocyte transition in chronic kidney disease rats (Q93048783) (← links)